Evidence map›Paper›PMID 37202167›Full record

ArticleNeurology2023

Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.

Adriano Chiò, Cristina Moglia, Antonio Canosa, Umberto Manera, Maurizio Grassano, Rosario Vasta, Francesca Palumbo, Salvatore Gallone, Maura Brunetti, Marco Barberis and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Concomitant presence of a novel ARPP21 variant and CNVs in Chinese familial amyotrophic lateral sclerosis-frontotemporal dementia patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 2 countries.

Adriano ChiòFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy. adriano.chio@unito.it.
Cristina MogliaFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Antonio CanosaFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Umberto ManeraFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Maurizio GrassanoFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0001-6714-6897
Rosario VastaFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Francesca PalumboFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0002-7070-2409
Salvatore GalloneFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Maura BrunettiFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Marco BarberisFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0002-7458-5174
Fabiola De MarchiFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0003-4366-0167
Clifton DalgardFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0003-2025-8239
Ruth ChiaFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0002-4709-7423
Gabriele MoraFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.ORCID 0000-0002-8388-2373
Barbara IazzolinoFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Laura PeottaFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Bryan J TraynorFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Lucia CorradoFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Sandra D'AlfonsoFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Letizia MazziniFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
Andrea CalvoFrom the "Rita Levi Montalcini" Department of Neuroscience (A. Chiò, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chiò, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Città della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chiò, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carità Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology & Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.
MACOM (United States) · US

Funding

Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
Intramural NIH HHS Z01 AG000949
6 · The paper itself

Abstract

BACKGROUND AND

objectivesDespite recent advances, it is not clear whether the various genes/genetic variants related to amyotrophic lateral sclerosis (ALS) interact in modifying patients' phenotype. The aim of this study was to determine whether the copresence of genetic variants related to ALS has interactive effects on the course of the disease.

methodsThe study population includes 1,245 patients with ALS identified through the Piemonte Register for ALS between 2007 and 2016 and not carrying superoxide dismutase type 1, TAR DNA binding protein, and fused in sarcoma pathogenic variants. Controls were 766 Italian participants age-matched, sex-matched, and geographically matched to cases. We considered Unc-13 homolog A (

resultsThe median survival time of the whole cohort was 2.67 years (interquartile range [IQR] 1.67-5.25). In univariate analysis, only DISCUSSION: We showed that gene variants acting as modifiers of ALS survival or phenotype can act on their own or in unison. Overall, 54% of patients carried at least 1 detrimental common variant or repeat expansion, emphasizing the clinical impact of our findings. In addition, the identification of the interactive effects of modifier genes represents a crucial clue for explaining ALS clinical heterogeneity and should be considered when designing and interpreting clinical trials results.

Indexed as

Amyotrophic Lateral SclerosisAllelesC9orf72 ProteinHumansPhenotypePrognosisC9orf72 Protein

Identifiers

PMID37202167
PMCPMC10351316
OpenAlexW4377013992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.